Siltartoxatug injection to prevent tetanus after injury

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational registry that documents the injury and wound characteristics of patients who receive Siltartoxatug for tetanus prophylaxis. Enrolled participants will be followed for 90 days after administration to determine whether tetanus occurs. The registry will collect selective safety data, including adverse reactions and serious adverse events, after Siltartoxatug administration. Data are being collected at multiple hospital sites in China without altering standard clinical care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 1.Having received or will receive Siltartoxatug for tetanus prophylaxis following injury;
* 2\. Provided signed informed consent by themselves or their legal representatives.

Exclusion Criteria:

* None

Where it's running

• Shaoxing Central Hospital
  Shaoxing, Zhejiang, China Recruiting
• The Second Affiliated Hospital of Shantou University
  Shantou, Guangdong, China Not yet recruiting
• Xiangyun County People's Hospital
  Xiangyun, Yunnan, China Not yet recruiting
• Zhoushan Putuo District People's Hospital
  Zhoushan, Zhejiang, China Not yet recruiting

Study contacts

• Study coordinator: Xia Qu, Master
• Email: sammi.qu@trinomab.com
• Phone: +86 0756 726399

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Two-Component Diphtheria-Tetanus-Pertussis Vaccine in Adults and Adolescents

  This trial tests different doses of an absorbed acellular pertussis-containing DTP vaccine in people aged 10 and older to see how well it works and how safe it is.

  Recruiting Phase 2 Changchun BCHT Biotechnology Co. · Lishui, Zhejiang · NCT07894055

• Diphtheria, Tetanus, Pertussis, and Poliovirus Vaccine Trial in Young Children

  This is a small early-phase study testing a diphtheria, tetanus, pertussis and polio vaccine formulation in children from 2 months to 6 years to see if it is safe and can provoke an immune response.

  Recruiting Phase 1/2 Institute of Medical Biology, Chinese Academy of Medical Sciences · Chongqing, Chongqing Municipality and 2 other locations · NCT07891104

• Community spread of multiple infectious diseases in Cambodia from a One Health perspective

  This project will test how common and connected dengue, chikungunya, Zika, Japanese encephalitis, and West Nile infections are among people, animals, and the environment across Cambodia.

  Recruiting Institut Pasteur du Cambodge · Phnom Penh, Phnom Penh · NCT07358910

• Siltartoxatug for tetanus protection after injury

  This study tests whether siltartoxatug can protect adults after injury from tetanus and compares it with other passive immunizing options.

  Recruiting Zhuhai Trinomab Pharmaceutical Co., Ltd. · Hangzhou, Zhejiang · NCT07347938

• Web-based program to improve pregnant mothers' understanding of and intent to get influenza and Tdap vaccines.

  This trial will test whether a short web-based education program helps pregnant women understand and feel more likely to get influenza and Tdap vaccines.

  Recruiting at 4 sites Universiti Putra Malaysia · Bandar Baru Bangi, Selangor and 3 other locations · NCT06815250

• Tdap and RSV vaccines in pregnancy: same visit versus separate visits

  This project will see if giving the RSV and Tdap vaccines together at one prenatal visit or at separate visits is safe and protects pregnant people and their babies better.

  Recruiting at 3 sites Phase 4 Canadian Immunization Research Network · Vancouver, British Columbia and 3 other locations · NCT07097012

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.